ICU SeaStar Medical Holding Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: ICU

Price (delayed)

$3.53

Market cap

$15.56M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.97

Enterprise value

$8.73M

?
Relative Growth: Rel. Growth: 64
Relative Strength: Rel. Strength: 62
Relative Valuation: Rel. Valuation: 9
Relative Profitability: Rel. Profitability: 22
Highlights
The company's revenue has surged by 124% YoY and by 19% QoQ
The gross profit has soared by 115% YoY and by 19% from the previous quarter
The equity has declined by 41% since the previous quarter but it has grown by 29% year-on-year
ICU's quick ratio is down by 32% since the previous quarter but it is up by 28% year-on-year
ICU's gross margin is down by 4% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: https://www.seastarmedical.com
Peers: OFIX

Key stats

What are the main financial stats of ICU

ICU stock price

How has the SeaStar Medical Holding stock price performed over time
Intraday
0%
1 week
14.61%
1 month
5.37%
1 year
-69.57%
YTD
47.08%
QTD
-3.81%

Financial performance

How have SeaStar Medical Holding's revenue and profit performed over time
Revenue
$1.71M
Gross profit
$1.59M
Operating income
-$13.99M
Net income
-$13.63M
Gross margin
92.6%
Net margin
-795.5%
The company's revenue has surged by 124% YoY and by 19% QoQ
The gross profit has soared by 115% YoY and by 19% from the previous quarter
SeaStar Medical Holding's net margin has surged by 58% YoY and by 4% QoQ
SeaStar Medical Holding's operating margin has soared by 58% YoY

Price vs fundamentals

How does ICU's price correlate with its fundamentals

Growth

What is SeaStar Medical Holding's growth rate over time

Valuation

What is SeaStar Medical Holding stock price valuation
P/E
N/A
P/B
3.28
P/S
8.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.1
SeaStar Medical Holding's EPS has soared by 87% YoY and by 22% from the previous quarter
The price to book (P/B) is 73% higher than the last 4 quarters average of 1.9
The equity has declined by 41% since the previous quarter but it has grown by 29% year-on-year
The company's revenue has surged by 124% YoY and by 19% QoQ
The price to sales (P/S) is 16% lower than the last 4 quarters average of 10.0

Efficiency

How efficient is SeaStar Medical Holding business performance
SeaStar Medical Holding's ROS has soared by 58% YoY and by 4% from the previous quarter
The company's return on assets has surged by 53% YoY but it fell by 14% QoQ
ICU's ROE is down by 11% since the previous quarter

Dividends

What is ICU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ICU.

Financial health

How did SeaStar Medical Holding financials performed over time
The company's total assets is 99% higher than its total liabilities
ICU's quick ratio is down by 32% since the previous quarter but it is up by 28% year-on-year
ICU's current ratio is down by 31% since the previous quarter but it is up by 24% year-on-year
SeaStar Medical Holding's debt is 97% lower than its equity
SeaStar Medical Holding's debt has shrunk by 60% QoQ
The equity has declined by 41% since the previous quarter but it has grown by 29% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.